| Basics |
|
Kronos Bio, Inc.
|
| IPO Date: |
October 9, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$53.96M |
| Activated in VL: |
False |
| Average Daily Range |
| Avg Daily Range: |
$0.29 | 3.61%
|
| Avg Daily Range (30 D): |
$0.01 | 1.29%
|
| Avg Daily Range (90 D): |
$0.02 | 2.00%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.24M |
| Avg Daily Volume (30 D): |
.58M |
| Avg Daily Volume (90 D): |
.47M |
| Trade Size |
| Avg Trade Size (Sh.): |
132 |
| Avg Trade Size (Sh.) (30 D): |
493 |
| Avg Trade Size (Sh.) (90 D): |
488 |
| Institutional Trades |
| Total Inst.Trades: |
178 |
| Avg Inst. Trade: |
$2.56M |
| Avg Inst. Trade (30 D): |
$1.17M |
| Avg Inst. Trade (90 D): |
$1.17M |
| Avg Inst. Trade Volume: |
.21M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.62M |
| Avg Closing Trade (30 D): |
$1.17M |
| Avg Closing Trade (90 D): |
$1.17M |
| Avg Closing Volume: |
337.56K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-1.07
|
$-.14
|
$-.43
|
|
Diluted EPS
|
$-1.07
|
$-.14
|
$-.43
|
|
Revenue
|
$ 9.19M
|
$ 1.86M
|
$ 2.27M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -64.49M
|
$ -8.36M
|
$ -25.81M
|
|
Operating Income / Loss
|
$ -70.34M
|
$ -9.44M
|
$ -27.15M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 20.25M
|
$ M
|
$ 9.61M
|
|
PE Ratio
|
|
|
|
|
|
|